key: cord-0960376-ink0w3gf
authors: Liu, Zheng; Wang, Qian; Li, Jing; Liu, Jiaqi; Wang, Hui; Jia, Cuijiao; Xu, Leiqian; Wang, Xueyan
title: The correlation between severity scores in computed tomography lung scans and viral load in the severity of novel coronavirus 2019 progression
date: 2022-03-07
journal: J Clin Ultrasound
DOI: 10.1002/jcu.23159
sha: 288ff096f52090bf845167117d4006401b7651fc
doc_id: 960376
cord_uid: ink0w3gf

BACKGROUND: This study aimed to find the correlation between severe computed tomography (CT) lung scores and nasopharyngeal viral load (Ct value) in the severity of COVID‐19 disease progression. METHOD: In this study, 37 patients diagnosed with COVID‐19 were categorized into severely ill and not severely ill samples. Their Ct values, epidemiological data, lung CT, and laboratory test results were collected three times, respectively, on the first day of their hospital admission, 3–5 days thereafter, and prior to hospital discharge. Among the 37 patients, 8 progressed from not severely ill to severely ill; we also paid attention and observed changes in clinical parameters of COVID‐19 patients who entered our city from other cities (imported cases) and the infected local residents who contacted these imported patients (non‐imported cases). RESULTS: Among the 37 patients, the Ct values and lung severity scores (LSSs) were similar in imported and non‐imported cases (F = 0.59 and 2.56; p = 0.45 and 0.12, respectively) but the proportion of severely ill imported patients was significantly higher compared with non‐imported patients (F = 7.77; p = 0.01). Additionally, 21.6% of patients' illness worsened; lymphocyte counts and Ct values were significantly lowered, and C‐reactive protein and LSS significantly increased during COVID‐19 disease progression. Furthermore, LSS negatively correlated with lymphocyte and mononuclear cell counts, as well as Ct values (Pearson's rank = −0.763, −0.824, and −0.588; p = 0.028, 0.012, and 0.003, respectively). CONCLUSION: In the severity of COVID‐19 disease progression, nasopharyngeal viral load and lung CT severity were closely related, and LSS negatively correlated with lymphocyte and mononuclear cell counts, as well as Ct values.

confirmed following positive nucleic acid testing for the 2019 novel coronavirus (SARS-CoV-2) in sputum via a throat swab, as well as lower respiratory tract secretion using real-time fluorescence polymerase chain reaction (RT-PCR). Fluorescence RT-PCR is considered an important indicator of viral load 1,2 as it is used to detect the cycle threshold (Ct) values of largely coronavirus-expressed genes. A low Ct value represents a high viral load. Hence, the Guidelines on the Novel Coronavirus-Infected Pneumonia Diagnosis and Treatment (2020) recommends using it in this regard. 3 A study 4 has suggested that a correlation existed between the viral load, disease progression, and the spread of COVID-19. Chen 5 found that a change in Ct values was likely to make a COVID-19 patient with mild symptoms to develop into a severe case as part of the disease's progression. Specifically, based on Chen's results, five patients' Ct values showed a decreasing tendency, while two other patients had higher Ct values before or during disease severity progression.

A time window exists to help prevent patients infected with COVID-19 from deteriorating by providing clinical interventions.

Changes are observable via computed tomography (CT) imaging as it serves as an important tool for evaluating the severity of COVID-19. 6, 7 The CT lung scan results of patients may vary over time. For example, ground-glass opacity (GGO) is often observed at the initial stage, a crazy-paving pattern at the progressive stage and consolidation at the peak stage, as well as at the recovery stage when consolidation is gradually absorbed and fibrotic changes arise. [8] [9] [10] [11] Therefore, the dynamics of chest CT scans represent a means for evaluating COVID-19 conditions. The aggravation of clinical symptoms is another important indicator of disease progression. Commonly observed symptoms of COVID-19 include fever, cough, myalgia, fatigue, pneumonia, and dyspnea, while some patients experience a headache, diarrhea, hemoptysis, a runny nose, and expectoration. 12 These symptoms, along with a decrease in the oxygenation index (OI), indicate that the disease has worsened.

Treating severely ill cases of COVID-19 has become a major focus of research. Nonetheless, few studies have made a distinction between non-severely ill and severely ill patients with COVID-19 pneumonia in terms of clinical, laboratory, viral load, and radiological contexts. This study aimed to explore the correlation between viral load, lung severity score (LSS), and CT lung scans in the severity of COVID-19 progression to provide clinicians with a theoretical reference for the early diagnosis of critically ill patients. 

The data extracted from patient records included age, sex, epidemiology, comorbid conditions, symptoms at onset, the time from the onset of symptoms to hospital admission, vital signs on admission, laboratory test results during hospitalization, high-resolution CT imaging findings, virus clearance time, and clinical outcomes. For epidemiological factors, the record included the field "Wuhan imported," which was defined as travel to Wuhan city, Hubei (also labeled "imported case"). Conversely, we defined patients who had been in contact with recent travelers from Wuhan city as non-imported cases.

According to the Guidelines on the Novel Coronavirus Infected Pneumonia Diagnosis and Treatment (7th ed., 2020), 13 we classified the severity of the participants' disease as follows: (1) a mildly ill group, in which patients exhibited mild clinical symptoms and no imaging manifestations of pneumonia; (2) a moderately ill group, in which patients had a fever and respiratory symptoms, and signs of pneumonia were observed in imaging; (3) a severely ill group, in patients exhibited dyspnea, a respiratory rate ≥30 breaths/min, oxygen saturation (SpO2) ≤93% at a resting state, or arterial partial pressure of oxygen/oxygen concentration (FiO2) ≤300 mm Hg; pulmonary imaging showed marked lesion progression >50% within 24-48 h; (4) a critically ill group, in which patients who had any of the following symptoms had to be admitted to the intensive care unit: respiratory failure and requiring mechanical ventilation, or shock combined with the failure of other organs. Patients who were severely and critically ill were labeled "severely ill patients," while mildly/moderately ill patients were defined as "not severely ill patients."

Classification of the chest HRCT severity was primarily based on the invasion range and morphological characteristics of lesions as follows:

CT-1, GGO in ≤25% of the lung parenchyma; CT-2, GGO in 26%-50% of the lung parenchyma; CT-3, GGO and consolidation in 51%-75% of the lung parenchyma; CT-4, GGO and consolidation in ≥76% of the lung parenchyma. The extent of lesions in each lung lobe was evaluated applying a score ranging from 0 to 4. A summation of the scores from all five lobes provided the total CT severity score ranging from 0 to 20 (see Figure 1 ). 14,15

This study was divided into three periods, that is, "admission,"

"follow-up/exacerbation," and "predischarge" periods. All patients received their first high-resolution CT scan on hospital admission.

During the follow-up period (3-5 days) thereafter, depending on the severity of their clinical symptoms and FiO2 (≤300 mm Hg), patients received a second round of CT scans. When symptoms were completely relieved and nucleic acid results were negative after two consecutive tests, another lung CT scan was conducted. The scanning scope was set between the superior aperture of the thorax and the posterior costophrenic angle with a slice interval of 1 mm and a slice thickness of 1.25 mm. All CT images were analyzed by two senior radiologists. The nucleic acid test for COVID-19 was also divided into three periods, with the first period being nucleic acid (RT-PCR) for patients diagnosed with COVID-19 before admission. The results are reviewed by the municipal CDC on the same day and the diagnosis was confirmed unanimously. The second nucleic acid test was performed on the same day as the disease progression and the second lung CT, The third nucleic acid test was performed before discharge.

These were done using RT-PCR and the CT values were obtained.

The SPSS Statistics 21.0 (IBM) software program was used for analysis in this study. Continuous data were expressed as the mean and standard deviation or as a percentage, and categorical data were 

The 37 patients included in this study were enrolled and analyzed retrospectively (15 females and 22 males, mean age 42.14 ± 14.98 years; range, 19-83 years). Some of the 37 patients were accompanied by a previous medical history, which included chronic hepatitis B virus infection (35.14%, 13/37), hypertension (18.92%, 7/37), heart disease, and chronic lung structure destruction disease (each 5.41%, 2/37), and diabetes mellitus, kidney disease, and obesity (each 2.7%, 1/37).

The 37 patients were divided into 29 (78.4%) non-severe and 8 (21.6%) severe cases; the latter group included older members and had more men than women (p = 0.01). When comparing severe with non-severe cases, the former had significantly higher blood neutrophil counts, C-reactive protein, and procalcitonin (PCT) (p < 0.01) levels.

There was no statistical difference concerning viral load between the two groups (p = 0.59). Compared with non-severe patients, severe patients were admitted to a hospital earlier and remained there longer (p = 0.03, and 0.01, respectively) (see Table 1 ).

There were no statistical difference in the Ct value and lung CT severity score between imported and non-imported cases (F = 0.59, 2.56; p = 0.45, 0.12, respectively.) but the disease severity was significantly higher among imported compared with non-imported cases (F = 7.77; p = 0.01) (see Figure 2 and Table 1 ). and intralobular septal thickening (2.6%-18.4%). Lung CT images taken before hospital discharge showed interlobular septal thickening (31.6%). We scored lung CT images at three stages, that is, 4.86 ± 4.81, 4.66 ± 4.31, and 2.86 ± 3.06 (t = 5.45, 5.81, and 5.04, respectively, for all of these values, p < 0.01) (see Table 2 ).

T A B L E 1 Demographic, epidemiological characteristics, comorbidities, viral load, and clinical and laboratory findings of patients with no-severe and severe confirmed COVID-19 at admission Table 3 ).

When the patient's symptoms worsened and/or SpO2 ≤93% at a resting state, we re-performed nucleic acid tests via throat swab, lung CT, and laboratory tests, and analyzed the correlation between these data. 19 Another study showed that plasma viremia was generally associated with increased disease severity. 20 Our data also showed that the viral load in the nasopharynx was significantly increased in the disease progression from non-severely to severely ill patients (p < 0.01 At this stage, both viral infection and inflammatory factors will be involved in lung inflammation, and corresponding treatment strategies should be adopted to avoid the occurrence of Cytokine storm and the development of ARDS in patients. 22 In summary, this study found that when the severity of COVID-19 progressed, nasopharyngeal viral load and lung CT severity were closely related, and LSS negatively correlated with lymphocyte and mononuclear cell counts, as well as Ct values. Therefore, it is advised that by closely monitoring these indicators, early intervention measures can be taken to reduce the occurrence of mortality.

The authors declare no potential conflict of interest.

This study was conducted with approval from the Ethics Committee of The Petroleum Clinical Medical College of Hebei Medical University (KYLL-2020-06). This study was conducted in accordance with the declaration of Helsinki. The consent from the patient for the publication of the case was obtained.

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

https://orcid.org/0000-0001-7143-4242

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster

General Office of National Health Commission of the People's Republic of China

Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19

Correlation analysis between the viral load and the progression of COVID-19

National Health Commission of the People's Republic of China. Consensus on guidelines for the publication of the seventh trail version of the diagnosis and treatment plan of the novel coronavirus coronavirus

The role of CT imaging for management of COVID-19 in epidemic area: early experience from a university hospital

Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19)

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Coronavirus disease (COVID-19): spectrum of CT findings and temporal progression of the disease

Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges

General Office of National Health Commission of the People's Republic of China

CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients form Wuhan city

CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)

Ultra-absorptive nanofiber swabs for improved collection and test sensitivity of SARS-CoV-2 and other biological specimens

The trinity of COVID-19: immunity, inflammation and intervention

Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome

SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression

SARS-CoV-2 viral load is associated with increased disease severity and mortality

CT appearances, patterns of progression, and follow-up of COVID-19: evaluation on thin-section CT. Insights Imaging

Clinical efficacy of corticosteroids in the early stages of deterioration in COVID-19 pneumonia

The correlation between severity scores in computed tomography lung scans and viral load in the severity of novel coronavirus 2019 progression